Preformed Line Products (NASDAQ:PLPC – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Monday.
Preformed Line Products Stock Performance
Shares of PLPC opened at $133.67 on Monday. Preformed Line Products has a 52-week low of $109.01 and a 52-week high of $154.90. The stock’s 50-day simple moving average is $136.70 and its 200 day simple moving average is $134.50. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 2.81. The stock has a market capitalization of $660.46 million, a price-to-earnings ratio of 20.07 and a beta of 0.75.
Preformed Line Products (NASDAQ:PLPC – Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The technology company reported $2.33 earnings per share (EPS) for the quarter. The firm had revenue of $148.54 million for the quarter. Preformed Line Products had a net margin of 5.76% and a return on equity of 7.88%.
Institutional Investors Weigh In On Preformed Line Products
About Preformed Line Products
Preformed Line Products Company, together with its subsidiaries, designs and manufactures products and systems that are used in the construction and maintenance of overhead, ground-mounted, and underground networks for the energy, telecommunication, cable, data communication, and other industries. The company offers optical ground wire products to support, protect, terminate, and splice transmission and distribution lines, as well as bolted, welded, and compressed connectors for substations; and string hardware products, polymer insulators, wildlife protection, substation fittings, and motion control devices.
Recommended Stories
- Five stocks we like better than Preformed Line Products
- 3 Dividend Kings To Consider
- 3 Mid-Cap Medical Stocks Outperforming the Market
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- The Top-Ranked Insider Buys From April by Market Cap
- What to Know About Investing in Penny Stocks
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Preformed Line Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Preformed Line Products and related companies with MarketBeat.com's FREE daily email newsletter.